Why Dynorphin A Lasts Much Longer Than Dynorphin B in the Brain
Dynorphin B is broken down to leu-enkephalin 10,000 times faster than dynorphin A in brain tissue, explaining their very different signaling durations.
Quick Facts
What This Study Found
Dynorphin B was processed to leu-enkephalin at a 10,000-fold higher rate than dynorphin A in rat striatal extracts.
Key Numbers
How They Did This
Synthetic dynorphin peptides were incubated with rat striatal extracts. Breakdown products were identified by size-exclusion chromatography connected to electrospray ionization mass spectrometry.
Why This Research Matters
The stability of a peptide determines how long it acts. Dynorphin A's resistance to breakdown means it has a much longer signaling window than dynorphin B, which is rapidly converted to a different opioid signal (enkephalin).
The Bigger Picture
How fast a peptide is broken down determines how long its signal lasts. The huge difference in stability between dynorphin A and B means they play fundamentally different roles despite coming from the same precursor protein — like two messages sent from the same phone lasting seconds versus hours.
What This Study Doesn't Tell Us
In vitro study using brain tissue extracts. Degradation rates in isolated extracts may differ from rates in living brain tissue with active regulation.
Questions This Raises
- ?What enzymes are responsible for the rapid dynorphin B processing, and could they be therapeutic targets?
- ?Does the rapid conversion of dynorphin B to enkephalin represent a deliberate signaling switch rather than simple degradation?
Trust & Context
- Key Stat:
- 10,000x faster Dynorphin B is broken down 10,000 times faster than dynorphin A in brain tissue
- Evidence Grade:
- Preliminary — in vitro degradation study using brain extracts, which may not perfectly replicate in vivo conditions.
- Study Age:
- Published in 1995. The differential stability of dynorphin peptides remains an accepted finding, and the analytical approach pioneered here influenced subsequent peptide metabolism research.
- Original Title:
- Processing of prodynorphin-derived peptides in striatal extracts. Identification by electrospray ionization mass spectrometry linked to size-exclusion chromatography.
- Published In:
- Life sciences, 57(2), 123-9 (1995)
- Authors:
- Nylander, I(10), Tan-No, K(3), Winter, A, Silberring, J
- Database ID:
- RPEP-00336
Evidence Hierarchy
Frequently Asked Questions
What is the difference between dynorphin A and B?
Both come from the same precursor protein, but dynorphin A is much more resistant to breakdown. Dynorphin A signals for extended periods at kappa opioid receptors, while dynorphin B is rapidly converted to enkephalin, switching to a different opioid signal.
Why does peptide stability matter?
A peptide that breaks down in seconds sends a brief signal, while one that lasts minutes or hours has sustained effects. For drug design, stability determines whether a peptide can work long enough to be therapeutic.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00336APA
Nylander, I; Tan-No, K; Winter, A; Silberring, J. (1995). Processing of prodynorphin-derived peptides in striatal extracts. Identification by electrospray ionization mass spectrometry linked to size-exclusion chromatography.. Life sciences, 57(2), 123-9.
MLA
Nylander, I, et al. "Processing of prodynorphin-derived peptides in striatal extracts. Identification by electrospray ionization mass spectrometry linked to size-exclusion chromatography.." Life sciences, 1995.
RethinkPeptides
RethinkPeptides Research Database. "Processing of prodynorphin-derived peptides in striatal extr..." RPEP-00336. Retrieved from https://rethinkpeptides.com/research/nylander-1995-processing-of-prodynorphinderived-peptides
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.